Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference41 articles.
1. Clear-cell cancer of the ovary-is it chemosensitive Int J Gynecol C;Pather;ancer,2005
2. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types A study of 1411 clear cell ovarian cancers.;Chan;Gynecol Oncol,2008
3. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.;Pectasides;Gynecol Oncol,2006
4. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.;Ho;Gynecol Oncol,2004
5. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.;Mahdi;Int J Gynecol Cancer,2013
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601;Anti-Cancer Drugs;2022-12-05
2. Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma;Cancers;2021-06-25
3. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers;Gynecologic Oncology;2021-01
4. Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer;Journal of Obstetrics and Gynaecology Canada;2020-10
5. Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases;Cancer Management and Research;2020-02
Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3